Haemoglobinopathies congenital Completed Phase 2 Trials for Hydroxyurea (DB01005)

Also known as: Haemoglobinopathies / Haemoglobinopathy / Hemoglobinopathy / Hemoglobinopathies / Haemoglobinopathy NOS / Abnormal hemoglobin NOS

IndicationStatusPhase
DBCOND0026458 (Haemoglobinopathies congenital)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00001958Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)Treatment
NCT00000602Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)Treatment